Time-dependent predictive accuracy of noninvasive liver scores for chronic kidney disease onset in metabolic dysfunction-associated steatotic liver disease

Figure 1 Kaplan-Meier failure curve for cumulative chronic kidney disease probability of metabolic dysfunction-associated steatotic liver disease patients stratified by noninvasive scores. A: Non-alcoholic fatty liver disease fibrosis score; B: Fibrosis-4; C: Liver stiffness measurement; D: Albumin-bilirubin score. NFS: Non-alcoholic fatty liver disease fibrosis score; FIB-4: Fibrosis-4; LSM: Liver stiffness measurement; ALBI: Albumin-bilirubin; CKD: Chronic kidney disease.

Figure 2 Area under the receiver operating characteristic curves of non-alcoholic fatty liver disease fibrosis score, fibrosis-4, liver stiffness measurement and albumin-bilirubin score for predicting chronic kidney disease. A: 1-year chronic kidney disease (CKD); B: 2-year CKD; C: 3-year CKD; D: 4-year CKD; E: 5-year CKD; F: Time-dependent area under the receiver operating characteristic curve for CKD. NFS: Non-alcoholic fatty liver disease fibrosis score; FIB-4: Fibrosis-4; LSM: Liver stiffness measurement; ALBI: Albumin-bilirubin; CKD: Chronic kidney disease; AUROC: Area under the receiver operating characteristic curve.